Current NDC auxiliary source row compounder:579

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5593
Product Ndc: 26436-5593
Product Ndc Digits: 264365593
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Glutamine Arginine HCl Carnitine 25/100/100mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Glutamine (L), Arginine HCl, Carnitine (L)
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: ARGININE HYDROCHLORIDE; CARNITINE; GLUTAMINE
Active Ingredients Info: 100 mg/1 mL; 100 mg/1 mL; 25 mg/1 mL
History Active Ingredients Raw: ARGININE HYDROCHLORIDE; CARNITINE; GLUTAMINE
History Active Ingredients Info Raw: 100 mg/1 mL; 100 mg/1 mL; 25 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 26436-5593-3
Package Ndc: 26436-5593-3
Package Ndc Digits: 2643655933
Package Ndc11: 26436559303
Package Description: 30 mL in 1 VIAL, MULTI-DOSE (26436-5593-3)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:579
Source Row Number: 579
Source Row Hash: dd7c6571724744a1057d47c40bf925879a0ef0522aaa7d7ab4ded75171956b9f
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR",
    "PRODUCTNDC": "26436-5593",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "ARGININE HYDROCHLORIDE; CARNITINE; GLUTAMINE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "26436-5593-3",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Glutamine Arginine HCl Carnitine 25/100/100mg/mL",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Glutamine (L), Arginine HCl, Carnitine (L)",
    "PACKAGEDESCRIPTION": "30 mL in 1 VIAL, MULTI-DOSE (26436-5593-3) ",
    "ACTIVEINGREDIENTSINFO": "100 mg/1 mL; 100 mg/1 mL; 25 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:579
Source Row Number: 579
Status Scope: package
Lookup Ndc: 26436-5593-3
Lookup Ndc Digits: 2643655933
Product Ndc: 26436-5593
Product Ndc Digits: 264365593
Package Ndc: 26436-5593-3
Package Ndc Digits: 2643655933
Package Ndc11: 26436559303
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: dd7c6571724744a1057d47c40bf925879a0ef0522aaa7d7ab4ded75171956b9f
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51